Company profile
Ticker
INSD
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Instadose Pharma Corp., Mikrocoze Inc.
SEC CIK
Latest filings (excl ownership)
8-K
Other Events
19 Sep 23
DEF 14C
Information statement
2 Aug 23
PRE 14C
Preliminary information
21 Jul 23
8-K
Entry into a Material Definitive Agreement
7 Jul 23
8-K
Departure of Directors or Certain Officers
7 Nov 22
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4 Nov 22
8-K
Other Events
28 Sep 22
NT 10-K
Notice of late annual filing
29 Aug 22
10-Q
2022 Q3
Quarterly report
9 May 22
NT 10-Q
Notice of late quarterly filing
14 Apr 22
Latest ownership filings
No filings
Financial summary
Quarter (USD) | Feb 22 | Nov 21 | Aug 21 | May 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Nov 21 | Nov 20 | Nov 19 | Nov 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 5.33 k | 5.33 k | 5.33 k | 5.33 k | 5.33 k | 5.33 k |
Cash burn (monthly) | 4.01 k | (no burn) | 222.24 k | 101.27 k | (no burn) | (no burn) |
Cash used (since last report) | 100.22 k | n/a | 5.56 mm | 2.53 mm | n/a | n/a |
Cash remaining | -94.89 k | n/a | -5.55 mm | -2.53 mm | n/a | n/a |
Runway (months of cash) | -23.7 | n/a | -25.0 | -25.0 | n/a | n/a |